✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (248 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
36.50
3,98,362
67.05
1,66,228
61.43
1,39,575
22.54
1,04,719
18.17
1,01,160
21.78
99,034
18.84
93,031
50.85
90,471
23.11
80,578
28.68
67,996
58.61
62,423
71.07
59,938
96.48
58,296
35.49
54,088
92.11
41,567
40.26
41,104
40.99
37,295
34.38
34,884
42.20
31,807
34.72
30,202
33.25
28,165
1,046
23,032
25.86
22,073
66.16
22,027
105
21,130
-
20,045
67.38
19,338
106
19,065
43.67
18,855
12.08
18,809
891
17,923
30.57
16,678
23.79
14,960
42.80
14,880
33.53
14,509
21.56
13,229
93.92
12,619
22.29
12,119
26.57
11,663
56.47
11,389
34.97
10,929
44.40
10,661
50.67
10,489
66.75
9,975
17.90
9,156
118
9,089
28.70
8,424
26.33
8,378
24.81
8,106
22.25
8,019
52.11
7,818
53.97
7,485
24.52
7,199
29.60
6,326
27.15
5,884
-
5,565
27.20
5,039
-
4,696
-
4,506
30.90
4,092
42.75
3,830
74.55
3,563
33.44
3,397
21.85
3,326
16.35
3,313
16.32
3,306
58.33
2,919
26.44
2,884
149
2,818
23.69
2,746
22.38
2,658
8.29
2,444
7.58
2,417
-
2,338
-
2,313
23.19
2,306
148
2,105
-
2,078
-
1,960
28.06
1,873
29.42
1,674
29.16
1,649
49.17
1,434
40.07
1,406
18.02
1,375
54.28
1,369
32.38
1,324
21.90
1,315
18.66
1,287
31.19
1,277
5.05
1,254
13.96
1,226
35.26
1,152
21.20
1,109
46.29
1,073
25.18
1,068
30.35
1,003
10.55
926
21.14
908
44.08
884
-
844
-
836
19.41
812
37.39
767
44.25
732
45.27
722
35.25
637
46.13
617
50.73
533
26.68
529
19.44
506
68.94
481
39.45
477
14.45
469
44.24
425
19.72
391
38.01
358
71.73
352
43.70
351
29.98
348
33.04
319
-
313
89.52
296
25.04
294
30.22
290
-
287
46.89
273
24.26
258
14.68
258
82.33
255
29.29
252
30.76
252
25.45
250
71.75
247
22.21
245
-
234
-
220
20.80
217
26.15
216
-
211
30.81
205
14.91
187
8.64
187
13.31
181
-
179
18.48
178
660
171
32.02
171
6.93
168
55.81
165
36.41
164
13.19
162
31.74
152
10.73
150
55.97
146
12.27
143
28.42
137
536
135
28.18
129
16.11
129
-
128
18.69
126
15.21
124
-
120
31.95
118
204
116
12.97
111
-
109
12.55
109
14.72
100
26.25
98
19.21
91
14.83
91
74.24
90
120
89
31.21
87
10.86
78
4.34
77
-
77
-
76
6.47
69
15.61
68
-
68
15.15
65
14.22
64
-
60
12.52
60
11.80
58
13.27
56
-
55
19.94
55
7.49
54
130
52
15.56
52
21.03
52
210
47
-
45
-
44
18.38
43
55.94
43
21.85
42
94.92
42
51.43
41
-
38
-
38
34.87
37
23.72
37
-
37
-
35
-
32
35.81
31
13.61
31
350
30
6.45
27
-
26
29.91
26
6.32
26
27.61
25
7.14
24
10.69
22
-
21
10.12
21
37.79
17
-
16
51.21
15
-
15
22.17
14
42.05
14
100
13
963
13
12.96
13
-
12
25.17
12
-
12
67.38
10
-
10
9.03
9
-
8
-
7
89.76
7
824
7
-
7
-
5
-
5
66.51
4
37.62
4
-
3
-
2
Showing 5 248 of 248 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material